St. Jude Medical Inc. Fourth Quarter Earnings Sneak Peek
S&P 500 (NYSE:SPY) component St. Jude Medical, Inc. (NYSE:STJ) will unveil its latest earnings on Wednesday, January 25, 2012. St. Jude Medical develops, manufactures and distributes cardiovascular medical devices.
St. Jude Medical, Inc. Earnings Preview Cheat Sheet.
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 84 cents per share, a rise of 12% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 8.6% versus last year to $3.27.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 2 cents, reporting net income of 78 cents per share against a mean estimate of profit of 76 cents per share.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 3.7% in revenue from the year-earlier quarter to $1.4 billion.
Analyst Ratings: Analysts are bullish on this stock with 19 analysts rating it as a buy, none rating it as a sell and 14 rating it as a hold.
A Look Back: In the third quarter, profit rose 8.7% to $226.5 million (69 cents a share) from $208.4 million (63 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 11.5% to $1.38 billion from $1.24 billion.
Revenue has risen the past four quarters. Revenue rose 10.2% in the second quarter from the year earlier, climbed 9% in the first quarter from the year-ago quarter and 12.2% in the fourth quarter of the last fiscal year.
The increase in profit in the third quarter broke a streak of two consecutive quarters of year-over-year profit decreases. The figure dropped 5.2% in the second quarter and 2.2% in the first quarter.
Competitors to Watch: Medtronic, Inc. (NYSE:MDT), Boston Scientific Corp. (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), Hansen Medical, Inc. (NASDAQ:HNSN), Greatbatch Inc. (NYSE:GB), AtriCure Inc. (NASDAQ:ATRC), Volcano Corporation (NASDAQ:VOLC), C.R. Bard, Inc. (NYSE:BCR), and Stereotaxis, Inc. (NASDAQ:STXS).
Stock Price Performance: During December 19, 2011 to January 19, 2012, the stock price had risen $6.59 (20.6%) from $31.97 to $38.56. The stock price saw one of its best stretches over the last year between February 4, 2011 and February 14, 2011 when shares rose for seven-straight days, rising 13% (+$5.33) over that span. It saw one of its worst periods between December 7, 2011 and December 19, 2011 when shares fell for nine-straight days, falling 14.1% (-$5.24) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.